Pyridyl-alanine as a Hydrophilic, Aromatic Element in Peptide Structural Optimization

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Endocrinology

Background:

• Glucagon (Gcg) is crucial for regulating blood glucose and preventing hypoglycemia.
• Native glucagon exhibits poor solubility and stability, limiting its therapeutic use.
• Developing stable and soluble glucagon analogues is essential for pharmaceutical applications.

Purpose of the Study:

• To engineer novel glucagon analogues with improved aqueous solubility and stability at neutral pH.
• To evaluate the biophysical properties and pharmacological efficacy of these new analogues.
• To assess the utility of pyridyl-alanine (Pal) as a surrogate for aromatic amino acids in peptide drug design.

Main Methods:

• Chemical synthesis of glucagon analogues incorporating 3- and 4-pyridyl-alanine (3-Pal, 4-Pal) and Aib16.
• Assessment of aqueous solubility and stability at neutral pH.
• Pharmacological evaluation in rat and pig models of insulin-induced hypoglycemia.

Main Results:

• Novel glucagon analogues, particularly Gcg[Aib16] and those with Pal substitutions, demonstrated enhanced solubility and stability.
• Analogue 9 (Gcg[3-Pal6,10,13, Aib16]) exhibited superior biophysical characteristics and comparable efficacy to native glucagon in preclinical models.
• Pyridyl-alanine proved to be a versatile amino acid surrogate for improving peptide drug properties.

Conclusions:

• Pyridyl-alanine incorporation is an effective strategy for enhancing the medicinal suitability of glucagon.
• The developed glucagon analogues represent promising candidates for treating hypoglycemia.
• This approach can be broadly applied to refine the biophysical properties of other peptide therapeutics.